Targeted ultrasound therapy offers a less invasive prostate cancer treatment designed to minimize disruption to daily life.

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

A retired Winnipeg teacher who raised money for his own prostate cancer treatment after learning that provincial health ...

Research team at OncoRay identifies MMP11 as a promising biomarker for liquid biopsy in prostate cancer Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In ...

Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...

Performed in a single session without any surgical incisions or scarring, the treatment utilizes an advanced fusion-guided system that combines magnetic resonance imaging (MRI) with precise prostate ...

Former President Joe Biden made a rare public appearance at the Friday, March 6, funeral for Jesse Jackson amid his cancer battle. Biden, 83, attended the ceremony for the civil rights activist — who ...

Sunshine Coast University Hospital to see $2.3 million service expansion. In a Southern Hemisphere first, the service now offers a new Cone Beam CT ...

Five-year survival rates are among the lowest of all cancers, at about 25%. But when caught early enough – through annual CT ...

PYLARIFY TruVu™ (piflufolastat F 18) injection (also known as 18F-DCFPyL or PyL) is a fluorinated small molecule PSMA-targeted PET imaging agent that enables visualization of lymph nodes, bone and ...

Firefighting has long been known as a dangerous profession. But today, flames aren’t the leading threat — occupational cancer ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...